Murdoch Childrens Research Institute, Centre for Community Child Health, Royal Children's Hospital, Parkville VIC 3052, Australia Department of Paediatrics, University of Melbourne, Melbourne, VIC, Australia
Murdoch Childrens Research Institute, Centre for Community Child Health, Royal Children's Hospital, Parkville VIC 3052, Australia Department of Paediatrics, University of Melbourne, Melbourne, VIC, Australia.
BMJ. 2015 Jan 20;350:h68. doi: 10.1136/bmj.h68.
To examine whether behavioural strategies designed to improve children's sleep problems could also improve the symptoms, behaviour, daily functioning, and working memory of children with attention deficit hyperactivity disorder (ADHD) and the mental health of their parents.
Randomised controlled trial.
21 general paediatric practices in Victoria, Australia.
244 children aged 5-12 years with ADHD attending the practices between 2010 and 2012.
Sleep hygiene practices and standardised behavioural strategies delivered by trained psychologists or trainee paediatricians during two fortnightly consultations and a follow-up telephone call. Children in the control group received usual clinical care.
At three and six months after randomisation: severity of ADHD symptoms (parent and teacher ADHD rating scale IV-primary outcome), sleep problems (parent reported severity, children's sleep habits questionnaire, actigraphy), behaviour (strengths and difficulties questionnaire), quality of life (pediatric quality of life inventory 4.0), daily functioning (daily parent rating of evening and morning behavior), working memory (working memory test battery for children, six months only), and parent mental health (depression anxiety stress scales).
Intervention compared with control families reported a greater decrease in ADHD symptoms at three and six months (adjusted mean difference for change in symptom severity -2.9, 95% confidence interval -5.5 to -0.3, P=0.03, effect size -0.3, and -3.7, -6.1 to -1.2, P=0.004, effect size -0.4, respectively). Compared with control children, intervention children had fewer moderate-severe sleep problems at three months (56% v 30%; adjusted odds ratio 0.30, 95% confidence interval 0.16 to 0.59; P<0.001) and six months (46% v 34%; 0.58, 0.32 to 1.0; P=0.07). At three months this equated to a reduction in absolute risk of 25.7% (95% confidence interval 14.1% to 37.3%) and an estimated number needed to treat of 3.9. At six months the number needed to treat was 7.8. Approximately a half to one third of the beneficial effect of the intervention on ADHD symptoms was mediated through improved sleep, at three and six months, respectively. Intervention families reported greater improvements in all other child and family outcomes except parental mental health. Teachers reported improved behaviour of the children at three and six months. Working memory (backwards digit recall) was higher in the intervention children compared with control children at six months. Daily sleep duration measured by actigraphy tended to be higher in the intervention children at three months (mean difference 10.9 minutes, 95% confidence interval -19.0 to 40.8 minutes, effect size 0.2) and six months (9.9 minutes, -16.3 to 36.1 minutes, effect size 0.3); however, this measure was only completed by a subset of children (n=54 at three months and n=37 at six months).
A brief behavioural sleep intervention modestly improves the severity of ADHD symptoms in a community sample of children with ADHD, most of whom were taking stimulant medications. The intervention also improved the children's sleep, behaviour, quality of life, and functioning, with most benefits sustained to six months post-intervention. The intervention may be suitable for use in primary and secondary care.Trial registration Current Controlled Trials ISRCTN68819261.
研究旨在改善儿童睡眠问题的行为策略是否也能改善患有注意缺陷多动障碍(ADHD)的儿童的症状、行为、日常功能和工作记忆以及其父母的心理健康。
随机对照试验。
澳大利亚维多利亚州的 21 家普通儿科诊所。
2010 年至 2012 年期间在这些诊所就诊的 244 名 5-12 岁患有 ADHD 的儿童。
由经过培训的心理学家或实习儿科医生在两次两周一次的咨询和一次随访电话中提供睡眠卫生实践和标准化行为策略。对照组的儿童接受常规临床护理。
随机分组后 3 个月和 6 个月:ADHD 症状严重程度(家长和教师 ADHD 评定量表 IV-主要结局)、睡眠问题(家长报告的严重程度、儿童睡眠习惯问卷、活动记录仪)、行为(强弱困难问卷)、生活质量(儿科生活质量量表 4.0)、日常功能(每日家长对傍晚和早晨行为的评定)、工作记忆(儿童工作记忆测试电池,仅 6 个月)和家长心理健康(抑郁焦虑压力量表)。
与对照组家庭相比,干预组在 3 个月和 6 个月时 ADHD 症状的改善程度更大(症状严重程度变化的调整平均差异-2.9,95%置信区间-5.5 至-0.3,P=0.03,效应大小-0.3,和-3.7,-6.1 至-1.2,P=0.004,效应大小-0.4)。与对照组儿童相比,干预组儿童在 3 个月时(56%比 30%;调整后的优势比 0.30,95%置信区间 0.16 至 0.59;P<0.001)和 6 个月时(46%比 34%;0.58,0.32 至 1.0;P=0.07)中度至重度睡眠问题较少。在 3 个月时,这相当于绝对风险降低 25.7%(95%置信区间 14.1%至 37.3%),估计需要治疗的人数为 3.9。在 6 个月时,需要治疗的人数为 7.8。干预对 ADHD 症状的有益影响约有一半至三分之一是通过改善睡眠来介导的,分别在 3 个月和 6 个月时。干预组家庭报告称,除了父母的心理健康外,其他儿童和家庭的结果都有较大的改善。教师报告称,在 3 个月和 6 个月时,儿童的行为都有所改善。与对照组儿童相比,干预组儿童在 6 个月时的工作记忆(倒背数字回忆)更高(平均差异 10.9 分钟,95%置信区间-19.0 至 40.8 分钟,效应大小 0.2)和 6 个月时(9.9 分钟,-16.3 至 36.1 分钟,效应大小 0.3);然而,只有一部分儿童完成了这一测量(3 个月时有 54 名儿童,6 个月时有 37 名儿童)。
一项简短的行为睡眠干预措施适度改善了 ADHD 社区样本儿童的 ADHD 症状严重程度,其中大多数儿童正在服用兴奋剂药物。该干预措施还改善了儿童的睡眠、行为、生活质量和功能,大多数益处可持续到干预后 6 个月。该干预措施可能适用于初级和二级保健。
当前对照试验 ISRCTN68819261。